Fred G. Weiss - 02 Jul 2021 Form 4 Insider Report for Osmotica Pharmaceuticals plc

Role
Director
Signature
By: /s/ Christopher Klein, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
02 Jul 2021
Net transactions value
$0
Form type
4
Filing time
07 Jul 2021, 16:05:26 UTC
Previous filing
22 Jun 2021
Next filing
03 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVLP Ordinary Shares Award $0 +61,188 +97% $0.000000 123,972 02 Jul 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units.